Advertisement

Topics

Companies Related to "Xoma Novartis Partner Beta MAbs Related" [Most Relevant Company Matches] [Advanced Search Results] RSS

13:33 EDT 26th April 2018 | BioPortfolio

Here are the most relevant search results for "Xoma Novartis Partner Beta MAbs Related" found in our extensive corporate database of over 50,000 company records.

Showing "Xoma Novartis Partner Beta MAbs Related" Companies 1–25 of 2,700+

Relevant

XOMA

XOMA is a leading biopharmaceutical company in the field of therapeutic antibody discovery and development. We have a royalty interest in one approved therapeutic antibody, RAPTIVA® (efalizumab), which is marketed in the United States, Europe and elsewhere, for the treatment of moderate-to-severe plaque psoriasis under an agreement with Genentech, Inc. as a result of a prior collaborative product...


NovImmune SA

NovImmune SA (‘NovImmune’) is a drug discovery and development company with a focus on therapeutic mAbs for inflammatory diseases and immune-related disorders. NovImmune has generated, to date, seven proprietary mAbs. The pipeline is a balance of preclinical and clinical compounds, with a mix of both clinically validated as well as novel targets....

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In ...


Beta Technology Ltd

Beta Technology Ltd is a private company established in 1984, by Dr Bob Keown OBE. Originally a lecturer in Metallurgy at Sheffield University, Bob set up his own consultancy company in 1984 and later went on to set up an employment agency hiring out scientists to industry such as British Steel (Corus), the National Physical Laboratory (NPL) and the Central Science Laboratory (CSL).Since then the ...

NovImmune

NovImmune SA ('NovImmune') is a drug discovery and development company with a focus on therapeutic mAbs for inflammatory diseases and immune-related disorders.

Beta Amyloid Org

Beta Amyloid.org keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is to provide anything and everything to the researchers at one website. Beta Amyloid.org access is totally free; however, we don’t endorse any scientific information. Our team of scientists, editors an...

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

BETA Healthcare Group

BETA Healthcare Group provides healthcare professional liability coverage to more than 150 hospitals and healthcare facilities in California. As the leading choice of liability insurers for California hospitals, BETA’s long-established commitment to California physicians continues to grow with more than 5,000 insured physicians and over 70 medical gro...

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the patients and physicians. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, pr...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

MabCure, N.V.

MabCure is a biotechnology company whose vision is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs) which will be developed as diagnostic tools, imaging agents and drugs to treat lethal cancers. MabCure’s initial goal...

MabCure, Inc.

MabCure is a biotechnology company whose vision is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs), which we plan to develop as diagnostic tools, imaging agents, and drugs to treat lethal cancers. MabCure’s initial g...

MabCure Inc.

MabCure is a biotechnology company whose vision is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs), which we plan to develop as diagnostic tools, imaging agents, and drugs to treat lethal cancers. MabCure’s initial g...

Y-mAbs Therapeutics, Inc.

Beta-Cell

Beta-Cell is engaged in the development and commercialisation of innovative cell and drug therapies for the treatment of diabetes. The primary therapeutic focus of the company is on beta-cells, the highly specialized endocrine cells located in pancreatic islets and responsible for producing insulin. Beta-Cell has an advanced pre-clinical xeno-transplantation program based on its proprietary techno...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product candidates to market, it also believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its...

CytoDyn Inc.

CytoDyn is a biotechnology company focused on developing subcutaneously delivered humanized cell-specific monoclonal antibodies (mAbs) as entry inhibitors for the treatment and prevention of Human Immunodeficiency Virus (HIV). The Company has one of the leading mAbs under development for HIV infection PRO 140 which is a Late Stage II humanized mAb with dem...

Elan

Elan Corporation, plc is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain. Elan's focus on improving the health of patients suffering from chronic and debilitating conditions is exemplified by its breakthrough research program in Alzheimer's disease, where it has...

Invenra, Inc.

Invenra is a pre-clinical stage bio-pharmaceutical company focused on discovering the next generation of best-in-class biologics, with an emphasis on monoclonal antibodies (mAbs), bispecific antibodies using their proprietary B-Body™ and TAIL™ platforms, empowered mAbs and their derivatives. Invenra’s proprietary technology combines state-of-the-ar...

RunE2E

Alpharetta, GA-based RunE2E is an SAP gold channel partner specializing in the setup and support of SAP CRM and related solutions, including eCommerce, mobile CRM and business analytics. Its flagship product, RunCRM, is a qualified SAP Business All-in-One partner solution available on-demand and on-premise. For more information, visit RunE2E at http://www.RunE2E.com

ARIUS Research Inc.

ARIUS Research Inc. is a biotechnology company dedicated to personalizing cancer therapy through the discovery and development of novel anticancer monoclonal antibodies (MAbs). Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST™, that rapidly identifies powerful MAbs targeting a variety of cancer indications. This antibody generation engine has enabled ARIUS to...

Aves Labs, Inc.

Aves Labs is committed to providing researchers with the highest quality custom antibody and custom anti-peptide antibody services. To this end, partnerships and collaborations are one of the pillars of our success. We seek partner development programs in four areas: Aves Labs will research and develop polyclonal antibodies, kits, and related products for your gene products of interest. Aves L...

Sonoma Partners LLC

Chicago-based Sonoma Partners LLC sells, customizes and implements Microsoft Dynamics CRM for enterprise and mid-size companies throughout the United States. Founded in 2001, it has worked exclusively with the product since the Beta release of version 1.0. Microsoft twice awarded Sonoma Partners as the Global Microsoft CRM Partner of the Year. In addition, Sonoma Partners has written multiple book...

ProteoTech Inc.

ProteoTech is a privately-held, drug development company that utilizes its amyloid expertise to discover and develop new drugs for treating misfolded protein disorders and amyloid diseases. ProteoTech’s lead small molecule drug, Systebryl™ (PTI-110), will soon be entering a Phase 1/2 proof-of-concept clinical trial in patients with AL (immunoglobulin ...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). Since the very beginning, Novartis Venture Fund (part of the worldwide life science company Novartis International AG) is a main customer for which Venture Valuation carries out all external ...


More From BioPortfolio on "Xoma Novartis Partner Beta MAbs Related"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks